Improving detection combined with targeted therapy for small hepatocellular carcinoma
- PMID: 31032285
- PMCID: PMC6462596
- DOI: 10.21037/atm.2019.01.19
Improving detection combined with targeted therapy for small hepatocellular carcinoma
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment on
-
Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.Radiology. 2018 Sep;288(3):878-886. doi: 10.1148/radiol.2018172743. Epub 2018 Jun 19. Radiology. 2018. PMID: 29916771
Similar articles
-
Additional diffusion-weighted imaging in the detection of new, very small hepatocellular carcinoma lesions after interventional therapy compared with conventional 3 T MRI alone.Clin Radiol. 2012 Jul;67(7):669-74. doi: 10.1016/j.crad.2011.12.006. Epub 2012 Feb 14. Clin Radiol. 2012. PMID: 22336669
-
Systemic gene-directed enzyme prodrug therapy of hepatocellular carcinoma using a targeted adenovirus armed with carboxypeptidase G2.Cancer Res. 2005 Jun 15;65(12):5003-8. doi: 10.1158/0008-5472.CAN-05-0393. Cancer Res. 2005. PMID: 15958540
-
Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial.JAMA. 2008 Apr 9;299(14):1669-77. doi: 10.1001/jama.299.14.1669. JAMA. 2008. Retraction in: JAMA. 2009 May 13;301(18):1931. doi: 10.1001/jama.2009.640. PMID: 18398079 Retracted. Clinical Trial.
-
Latest developments in targeted therapy for hepatocellular carcinoma.Expert Rev Anticancer Ther. 2010 Oct;10(10):1635-46. doi: 10.1586/era.10.146. Expert Rev Anticancer Ther. 2010. PMID: 20942634 Review.
-
Can Combined Therapy Benefit Immune Checkpoint Blockade Response in Hepatocellular Carcinoma?Anticancer Agents Med Chem. 2019;19(2):222-228. doi: 10.2174/1871520618666181114112431. Anticancer Agents Med Chem. 2019. PMID: 30426903 Review.
Cited by
-
Cancer nanotechnology: Enhancing tumor cell response to chemotherapy for hepatocellular carcinoma therapy.Asian J Pharm Sci. 2019 Nov;14(6):581-594. doi: 10.1016/j.ajps.2019.04.005. Epub 2019 Jun 12. Asian J Pharm Sci. 2019. PMID: 32104485 Free PMC article. Review.